By Regulators Struggle With Private Lab Failures
State regulators are spending unnecessary time and money policing a private cannabis testing model that fails to protect consumers. The problem spans multiple states and shows no sign of slowing.
New York shut down Lexachrom Analytical Laboratory. Michigan issued historic license revocations against Viridis Laboratories.
New Jersey has put out RFPs to audit its testing ecosystem. Maryland launched a new CSQ CLEAR audit pilot.
Despite these actions, regulators remain stuck in what the report calls an endless game of whack-a-mole. Bad behavior persists across state lines.
Regulators have issued fines, suspended licenses, and pulled operating permits for years. The enforcement has not stopped the underlying conduct.
Why THC Inflation Persists
Private labs rely on growers to stay in business, which creates a built-in financial incentive to cheat. Cultivators steer their business toward facilities willing to report higher THC percentages.
Consumer hyper-fixation on potency drives the demand for inflated numbers. Adding an extra 5% or 10% to a Certificate of Analysis drastically raises wholesale crop value.
If one lab refuses to play ball, the grower simply takes their testing batch down the street. This practice, known as lab shopping, has been called out by the industry for years.
Labs use standard tricks to hit inflated numbers, including moisture manipulation. As long as testing facilities compete for commercial clients, these practices remain standard operating procedure.
More regulations cannot fix the structure, according to the report. The financial conflict is baked into the private model itself.
The Push For State Run Testing
Regulators are now pushing to bring compliance testing directly under state authority. Under a state-operated model, cultivators would pay standard state fees to fulfill mandatory testing requirements.
Private deals, profit margins, and lab competition would disappear overnight. The change removes the financial incentive to inflate results.
States are currently burning public money on multi-lab audits, cross-testing pilots, and state contract RFPs. They are building complex forensic networks and hiring outside consultants just to catch bad data after the fact.
Programs like Maryland’s CSQ CLEAR pilot and New Jersey’s testing assessments will continue collecting data. But audits only diagnose the symptom, the report states.
A state-run model would streamline product safety and turn required compliance testing into a self-sustaining, revenue-generating function for the state. Until then, the private lab market will continue to privilege high THC numbers over scientific truth.
